Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Olanzapine 15mg oral lyophilisates sugar free
040201060AAAKAK
|
Olanzapine | Olanzapine | Central Nervous System | 188 |
|
Zyprexa 7.5mg tablets
040201060BBABAB
|
Zyprexa | Olanzapine | Central Nervous System | 166 |
|
Zyprexa 15mg tablets
040201060BBAHAL
|
Zyprexa | Olanzapine | Central Nervous System | 147 |
|
Zyprexa 15mg Velotabs
040201060BBAGAK
|
Zyprexa | Olanzapine | Central Nervous System | 108 |
|
Olanzapine 2.5mg/5ml oral solution
040201060AAAIAI
|
Olanzapine | Olanzapine | Central Nervous System | 69 |
|
Olanzapine 2.5mg orodispersible tablets sugar free
040201060AABGBG
|
Olanzapine | Olanzapine | Central Nervous System | 29 |
|
Olanzapine 7.5mg orodispersible tablets sugar free
040201060AABHBH
|
Olanzapine | Olanzapine | Central Nervous System | 9 |
|
Olanzapine 10mg powder for solution for injection vials
040201060AAANAN
|
Olanzapine | Olanzapine | Central Nervous System | 3 |
|
Zalasta 10mg orodispersible tablets
040201060BCAHAT
|
Zalasta | Olanzapine | Central Nervous System | 2 |
|
Zalasta 5mg tablets
040201060BCABAA
|
Zalasta | Olanzapine | Central Nervous System | 2 |
|
Olanzapine 1.25mg/5ml oral liquid
040201060AAAJAJ
|
Olanzapine | Olanzapine | Central Nervous System | 1 |
|
Olanzapine 12.5mg/5ml oral suspension
040201060AABBBB
|
Olanzapine | Olanzapine | Central Nervous System | 1 |
|
Zalasta 10mg tablets
040201060BCADAC
|
Zalasta | Olanzapine | Central Nervous System | 1 |
|
Arkolamyl 10mg orodispersible tablets
040201060BDAAAT
|
Arkolamyl | Olanzapine | Central Nervous System | No data available |
|
Arkolamyl 15mg orodispersible tablets
040201060BDABAU
|
Arkolamyl | Olanzapine | Central Nervous System | No data available |
|
Arkolamyl 20mg orodispersible tablets
040201060BDADAV
|
Arkolamyl | Olanzapine | Central Nervous System | No data available |
|
Arkolamyl 5mg orodispersible tablets
040201060BDACAS
|
Arkolamyl | Olanzapine | Central Nervous System | No data available |
|
Ceyxa 10mg powder for solution for injection vials
040201060BFAAAN
|
Ceyxa | Olanzapine | Central Nervous System | No data available |
|
Olanzapine 15mg/5ml oral solution
040201060AABCBC
|
Olanzapine | Olanzapine | Central Nervous System | No data available |
|
Olanzapine 5mg/5ml oral suspension
040201060AABFBF
|
Olanzapine | Olanzapine | Central Nervous System | No data available |
|
Olanzapine 6.5mg/5ml oral suspension
040201060AABEBE
|
Olanzapine | Olanzapine | Central Nervous System | No data available |
|
Olanzapine 6mg/5ml oral suspension
040201060AABDBD
|
Olanzapine | Olanzapine | Central Nervous System | No data available |
|
Xyquila 10mg powder for solution for injection vials
040201060BEAAAN
|
Xyquila | Olanzapine | Central Nervous System | No data available |
|
Zalasta 15mg orodispersible tablets
040201060BCAIAU
|
Zalasta | Olanzapine | Central Nervous System | No data available |
|
Zalasta 15mg tablets
040201060BCAEAL
|
Zalasta | Olanzapine | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.